This SARS-CoV-2 Nucleocapsid antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Predicted Reactivity
Predicted reactivity based on immunogen sequence: SARS-CoV Nucleocapsid proteins: (100%)
Purification
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid Antibody is affinity chromatography purified via peptide column.
Immunogen
Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid antibody was raised against a peptide corresponding to 17 amino acids near the carboxy terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid protein.
SARS-CoV-2 N
Reactivity: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
ELISA, IF
Host: Human
Monoclonal
CR3009 (03-009)
unconjugated
Recombinant Antibody
Application Notes
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid antibody can be used for the detection of SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid protein in ELISA. It will detect 4 ng of free peptide at 1 μg/mL.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid Antibody is supplied in PBS containing 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019-20 coronavirus outbreak.